GlassScriptPhysician profile
Brianne Bechard
NPI 1699316836
$1,467.71
in general payments reported to CMS, 2019-2025
21 companies · $72.56 in 2025
The $72.56 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $675 · 2022: $334 · 2023: $233 · 2024: $154 · 2025: $72.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $437.55 | 2021-2024 | Glassia, Cuvitru |
| Glaxosmithkline, LLC. | $164.44 | 2021-2023 | Shingrix |
| Baxter Healthcare | $100.07 | 2022-2024 | Fluid Systems - Drug Delivery Systems, Hillrom - Vest System Model 105 Home Care |
| Csl Behring | $99.45 | 2021-2022 | |
| Grifols USA, LLC | $87.60 | 2022-2024 | Prolastin-C Liquid |
| Revance Therapeutics, INC. | $72.56 | 2025 | Daxxify |
| Advanced Respiratory, INC | $61.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $58.25 | 2021-2022 | |
| Mylan Specialty L.P. | $49.73 | 2022-2023 | Yupelri |
| Genentech USA, INC. | $47.80 | 2021 | |
| Pfizer INC. | $46.23 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $45.92 | 2021 | |
| Inspire Medical Systems, INC. | $35.97 | 2024 | Inspire |
| Idorsia Pharmaceuticals US INC | $32.38 | 2023 | Quviviq |
| Lilly USA, LLC | $24.16 | 2024 | Jardiance, Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $19.96 | 2021 | |
| Novo Nordisk INC | $19.18 | 2023 | Wegovy |
| Exact Sciences Corporation | $17.60 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $16.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.78 | 2021 | |
| Currax Pharmaceuticals LLC | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianne Bechard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.